The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector

The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased focus on the risks for medical device manufacturers and healthcare providers inherent in the data they collect and hold, including the risks posed by the ongoing threat of cyber-attacks. This is where the NIS2 Directive and the CER Directive come in.

In this article we will consider the Network and Information Systems Directive (EU) 2022/0383 (“NIS2”) and the Directive on the Resilience of Critical Entities (EU) 2022/2557 (“CER Directive”) and the impact that they will have on medical device manufacturers and healthcare providers.

Read the full article here

Latest insights

More Insights
fish farm

Agricultural Law Decree: what to expect?

May 09 2024

Read More
DNA blocks

Legal Win for NanoString and Bruker in patent battle

May 09 2024

Read More
Colourful building

Pillar Two, the new global minimum tax: ten matters CFO’s and Tax Directors should know (and may be questioned on)

May 08 2024

Read More